AACE Current News

World Medical Association (WMA) 8th Version of the Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects

AACE endorses the World Medical Association (WMA) Declaration of Helsinki 8th Version – Ethical Principles for Medical Research Involving Human Subjects...



Targeted eye care education urged for adults with diabetes

The utilization of eye care among patients with diabetes requires education targeted at financial barriers and comprehension of ophthalmic implications of their disease, according to researchers....



Ultrasound May Cut Thyroid Biopsy Rate

Certain characteristics of thyroid nodules identified on ultrasound can help predict the likelihood of cancer, and may also help determine if fine-needle aspiration biopsy can be deferred, a large, single-center study suggested....



Obese Kids Face Immediate Heart Risks

Childhood obesity not only increases the risk of cardiovascular disease in later life, but also is linked to cardiovascular damage before adulthood based on evidence published in the Journal of the American College of Cardiology....



Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States

At rare, extremely high blood glucose levels (1024 mg/dL and above), the FreeStyle InsuLinx Blood Glucose Meter may provide an inaccurate reading....



New Thyroid Awareness website launched

The new Thyroid Awareness website has launched. Be sure to check out the new features!...



AACE EHR Survey 2012

In an effort to inform and educate our AACE members, as well as their clinical and administrative support staff, we have designed a survey to address the high points and low points you have encountered either as a current or prospective EHR user... ...



State of AACE and Council, Committees, Task Forces Annual Reports

In preparation for the AACE Annual Meeting in Phoenix, the State of AACE report for 2012-2013 can now be accessed. ...



FDA Approves Weight Management Drug Qsymia

The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management....



AACE response to new proposed recommendations from USPSTF on calcium and vitamin D

AACE response to the proposed recommendations from SPSTF that calcium and vitamin D do not protect against fracture and cancer risk...



AACE Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis Are Now Available

AACE Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis were recently published as a supplement to the March/April issue of Endocrine Practice. ...



FDA MedWatch - Monthly Safety Labeling Changes

The U.S. Food and Drug Administration (FDA) has released the April 2012 Safety Labeling Changes for 43 products, including a number of endocrine related drugs. ...



Delays in Medicare Reimbursement

AACE’s Socioeconomics & Member Advocacy Department has received several inquiries from the membership regarding delays they are experiencing in Medicare reimbursement. Three issues have been identified that may be impacting your office practice....



NEW!! AACE Lipid Guidelines Now Available

NEW!! AACE Lipid Guidelines Now Available. Each year, an estimated 785000 Americans will have a new coronary artery disease (CAD) event, and approximately 470000 will have a recurrent attack. CAD caused approximately 1 of every 6 deaths in the United Stat...



ASAP is Now Available for ABIM MOC/Credit!!!

The American College of Endocrinology Self Assessment Program (ASAP) was recently accepted as part of the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. For more details on how to participate, please visit: http://a...



STOP THE MEDICARE MELTDOWN!

AACE is partnering with the Texas Medical Association (TMA) and several other state and specialty societies on a petition drive to permanently repeal the flawed Medicare Sustainable Growth Rate (SGR) physician payment formula. The petition calls on Congre...



AACE to participate in 2nd World Congress on Interventional Therapies for Type 2 Diabetes

AACE will participate in the 2nd World congress on Interventional Therapies for Type 2 Diabetes, scheduled to be held in New York, March 28-30, 2011. AACE will be represented by Dr. Jeffrey Mechanick who will serve as a ...



This is the official Call for Nominations for the Fellow-in-Training Representative

This is the official Call for Nominations for the Fellow-in-Training Representative on the American Association of Clinical Endocrinologists' (AACE) Board of Directors for the 2011-2012 Association year. This is an excellent opportunity to actively partic...



Joint Statement by AACE, The American Thyroid Association, The Endocrine Society, and the Society of Nuclear Medicine on radioactive precautions following radioactive iodine therapy

View the Statement...



AACE Spotlight on Satellites - CME Credit Available!

Summaries of satellite symposia presented at the AACE 2010 Annual Meeting and Clinical Practice are published in Endocrine Practice Volume 16, Sept/Oct (Suppl 2)....



The long awaited Institute of Medicine report on "Dietary Reference Intakes for Calcium and Vitamin D" was released November 30th and is available

The long awaited Institute of Medicine report on "Dietary Reference Intakes for Calcium and Vitamin D" was released November 30th and is available at http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx. Key features of...



Please Pay Your 2011 AACE Dues

Dues paying members of AACE should have received numerous emails and their dues invoice for 2011 in the mail. You may pay your dues securely online by visiting: http://www.aace.com/membership/dues.php or by using the invoice you were sent. Please check yo...



FDA Drug Safety Alert on Heart Medication Dronedarone (Multaq)

FDA is alerting healthcare professionals and patients about cases of rare, but severe liver injury, including two cases of acute liver failure leading to liver transplant in patients treated with the heart medication dronedarone (Multaq). Dronedarone is a...



Important Recall for Triad Group Alcohol Prep Pads Affects Genetech Pre-packaged Medicines

The FDA has issued a recall involving all lots of alcohol prep pads, alcohol swabs, and alcohol swabsticks manufactured by the Triad Group due to concerns about potential contamination with Bacillus cereus. An alert was recently released noting that Triad...



The FDA has issued a drug safety communication updating the public

The FDA has issued a drug safety communication updating the public about new labeling information which has been added to the physician labeling and patient labeling (Medication Guide) on the cardiovascular risks (including heart attack) of the dr...



FDA issues product safety alert:

FDA issues product safety alert: Triad lubricating jelly products may not be sterile. Patients who are immuno-compromised, such as those with diabetes, cancer and certain other chronic diseases, may be at potential risk for infection. They were distribute...



CMS issues instructions to Medicare Contractors to reprocess claims affected by The Affordable Care Act And 2010 Medicare Physician Fee Schedule Changes

On March 23, 2010, President Obama signed into law the Affordable Care Act. Various provisions of the new law were effective April 1, 2010, or earlier and, therefore, were implemented some time after their effective date. In addition, corrections to the...



AACE and the American Diabetes Association (ADA) issue a joint statement in response to American College of Physicians (ACP) clinical guidelines for inpatient glucose control.

For more information please click here....



FDA Joint Committee hearing scheduled for Friday, September 9 to discuss the benefits and risks of long-term bisphosphonate use

FDA Joint Committee hearing scheduled for Friday, September 9 to discuss the benefits and risks of long-term bisphosphonate use for the treatment and prevention of osteoporosis in light of the emergence of the safety concerns of osteonecrosis of the jaw a...



Information on potential shortage of Thyrogen

Information on potential shortage of Thyrogen click here....



New study by the Institute for Alternative Futures

New study by the Institute for Alternative Futures identifies ten states where diabetes burden will be highest. http://www.altfutures.org/diabetes2025/ ...



RADIATION RISKS TO HEALTH

The growing concern surrounding the release of radiation from an earthquake and tsunami-stricken nuclear complex in Japan has raised fears of radiation exposure to populations in North America from the potential plume of radioactivity crossing the Pacific...



AACE Releases New Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan

To view the complete AACE guidelines, please Click Here. To view the news release, please Cli...



AS HEARD ON RADIO: The Complete Guide to Lifelong Nutrition

To order your copy of The Complete Guide to Lifelong Nutrition, as heard on the radio with Dr. Jeffrey Mechanick, use the following links: Physical Copy ...



FDA Issues Drug Safety Communication Containing An Updated Risk Evaluation and Mitigation Strategy Restricting Access to Avandia

Read the Announcement...



LEGISLATIVE UPDATE - AACE is pleased to announce that the US House of Representatives and the US Senate have both introduced the “Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011.”

This bill, sponsored by Representatives Michael Burgess (R-26th-TX) and Shelley Berkley (D-1st-NV) in the House, and by Senators Olympia Snowe (R-ME) and Debbie Stabenow (D-MI) in the Senate, would extend current Medicare payment rates for energy x-ray ab...



AACE Submits Comments on ACO Proposed Rules

AACE has submitted comments to CMS Administrator Donald Berwick regarding the proposed rule on the Accountable Care Organizations under the Medicare Shared Savings Program....



FDA announces new safety recommendations for high-dose simvastatin

FDA announces new safety recommendations for high-dose simvastatin Increased risk of muscle injury cited FDA Drug Safety Communication: New restrictions, contraindications,...



News On Actos

Recently, French and then German regulators have withdrawn approval for Actos therapy in type 2 diabetes owing to a small but significantly increased risk of urinary bladder cancer noted in 1 study in patients taking the drug for longer than 5 years. Japa...



The US FDA has revised its existing safety warning regarding pioglitazone.

Dear AACE Member, Following our news on Actos (pioglitazone) on 6-13-11. Today, The United States Food and Drug Administration (FDA) has revised its existing safety warning regarding pioglitazone for the treatment of diabetes. The FDA...



American Association of Clinical Endocrinologists, American Diabetes Association, and The Endocrine Society joint statement on Actos

American Association of Clinical Endocrinologists, American Diabetes Association, and The Endocrine Society joint statement on Actos...Read Joint Statement ...



FDA ANNOUNCES CLINICAL INVESTIGATOR TRAINING COURSE

The third annual FDA Clinical Investigator Training Course, co-sponsored by the Food and Drug Administration's (FDA) Office of Critical Path Programs and the Clinical Trials Transformation Initiative (CTTI), is now open for registration. The Course will ...



FDA Advisory Committee Votes 9 to 6 Not to Approve Dapagliflozin

Alan J. Garber, MD, PhD, FACE On July 19, 2011, the US Food and Drug Administration (FDA) conducted a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to evaluate the new drug application dapagliflozin, manu...



FDA Issues Drug Safety Communication on Ongoing safety review of oral osteoporosis drugs (bisphosphonates) and potential increased risk of esophageal cancer

To read more on this please visit http://www.fda.gov/Drugs/DrugSafety/ucm263320.htm ...



AACE Declares Obesity as a Disease State

AACE Declares Obesity as a Disease State: Read More...



Temporary supply shortage of Apidra® SoloSTAR® (insulin glulisine [rONA origin] injection) pens in the United States

Dear Healthcare Professional, We need to inform you of a temporary supply shortage of Apidra® SoloSTAR® pens in the United States, which may impact availability for your patients starting in late October 2011. ...



BYETTA is now approved as an add-on therapy to insulin glargine

the U.S. Food and Drug Administration (FDA) has approved a new use for BYETTA® (exenatide) injection. BYETTA is now approved as an add-on therapy to insulin glargine, with or without metformin and/or a thiazolidinedione (TZD), in conjunction with diet and...



Takeda Pharmaceuticals North America, Inc. has launched a new website

Takeda Pharmaceuticals North America, Inc. has launched a new website, ACTOSInfo.com, to provide patients and health care professionals with easily accessible and accurate information regarding ACTOS for the Treatment of Type 2 Diabetes. ...



AMA Secures Extension for E-Prescribing Hardship Exemption Deadline New Deadline November 8th

After hearing yesterday that some physicians were having difficulty accessing the CMS Communication Support Page, the AMA was able to work with CMS to secure an extension. The new deadline to file for an e-prescribing hardship exemption is Tuesday, Novem...



IAC and AACE Accreditation Webinar: Facility Accreditation

What Endocrinology Practices Need to Know to Comply with New CMS Rules All Nonhospital Providers of Nuclear Medicine, MR, CT and PET Must Be Accredited By January 1, 2012 – Is Your Facility Accredited? Thursday, December 1, 2011 at 6:00 p.m. EST ...



AACE
Guidelines

AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources

AACE
Publications

AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.